NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
18.57
+0.12 (0.65%)
At close: Jun 27, 2025, 4:00 PM
19.30
+0.73 (3.93%)
After-hours: Jun 27, 2025, 4:31 PM EDT
NAMS Employees
NewAmsterdam Pharma Company had 68 employees as of December 31, 2024. The number of employees increased by 39 or 134.48% compared to the previous year.
Employees
68
Change (1Y)
39
Growth (1Y)
134.48%
Revenue / Employee
$693,235
Profits / Employee
-$2,755,265
Market Cap
2.08B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 68 | 39 | 134.48% |
| Dec 31, 2023 | 29 | 12 | 70.59% |
| Dec 31, 2022 | 17 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAMS News
- 19 days ago - NewAmsterdam Pharma Announces Positive Topline Alzheimer's Disease Data from BROADWAY Clinical Trial - GlobeNewsWire
- 23 days ago - NewAmsterdam Pharma to Host R&D Day on June 11, 2025 - GlobeNewsWire
- 4 weeks ago - NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June - GlobeNewsWire
- 6 weeks ago - NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results - GlobeNewsWire
- 7 weeks ago - NewAmsterdam Pharma Announces Late-Breaking Data from BROADWAY and TANDEM Pivotal Studies Published in Leading Medical Journals and Presented at the European Atherosclerosis Society (EAS) Congress 2025 - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - NewAmsterdam Pharma to Present New Clinical and Preclinical Data at 93rd EAS Congress - GlobeNewsWire